​

OmniAb (OABI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

OmniAb Revenue Highlights

Latest Revenue (Y)

$18.67M

Latest Revenue (Q)

$2.24M

Main Segment (Y)

Service

OmniAb Revenue by Period

OmniAb Revenue by Year

DateRevenueChange
2025-12-31$18.67M-29.27%
2024-12-31$26.39M-22.75%
2023-12-31$34.16M-42.17%
2022-12-31$59.08M70.02%
2021-12-31$34.75M49.34%
2020-12-31$23.27M27.02%
2019-12-31$18.32M-

OmniAb generated $18.67M in revenue during NA 2025, up -29.27% compared to the previous quarter, and up 80.22% compared to the same period a year ago.

OmniAb Revenue by Quarter

DateRevenueChange
2025-09-30$2.24M-42.55%
2025-06-30$3.90M-6.19%
2025-03-31$4.15M-61.55%
2024-12-31$10.80M158.96%
2024-09-30$4.17M-45.21%
2024-06-30$7.61M100.32%
2024-03-31$3.80M-21.17%
2023-12-31$4.82M-11.96%
2023-09-30$5.48M-21.15%
2023-06-30$6.95M-58.95%
2023-03-31$16.92M-52.13%
2022-12-31$35.34M411.51%
2022-09-30$6.91M-4.01%
2022-06-30$7.20M-25.19%
2022-03-31$9.62M-55.36%
2021-12-31$21.56M243.43%
2021-09-30$6.28M12.39%
2021-06-30$5.58M-15.32%
2021-03-31$6.60M-50.51%
2020-12-31$13.33M167.25%
2020-09-30$4.99M-

OmniAb generated $2.24M in revenue during Q3 2025, up -42.55% compared to the previous quarter, and up 29.41% compared to the same period a year ago.

OmniAb Revenue Breakdown

OmniAb Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23
Service$7.26M$11.95M$12.18M
Royalty$878.00K$576.00K$1.28M

OmniAb's latest annual revenue breakdown by segment (product or service), as of Dec 25: Service (89.22%), and Royalty (10.78%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Dec 23Sep 23
Service$2.19M$1.19M$1.94M$1.95M$9.47M$2.48M$9.16M$3.02M
Royalty$218.00K$361.00K$111.00K$188.00K$258.00K$318.00K$834.00K$451.00K

OmniAb's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Service (90.96%), and Royalty (9.04%).

OmniAb Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CDXSCodexis$70.39M$8.60M
SGMOSangamo Therapeutics$57.80M$581.00K
IVVDInvivyd$53.43M$13.13M
IPHAInnate Pharma$51.90M$16.56M
OABIOmniAb$18.67M$2.24M
IMDXInsight Molecular Diagnostics$1.88M$260.00K
CCCCC4 Therapeutics--
TARAProtara Therapeutics--
RANIRani Therapeutics--
MISTMilestone Pharmaceuticals--

OABI Revenue FAQ

What is OmniAb’s yearly revenue?

OmniAb's yearly revenue for 2025 was $18.67M, representing a decrease of -29.27% compared to 2024. The company's yearly revenue for 2024 was $26.39M, representing a decrease of -22.75% compared to 2023. OABI's yearly revenue for 2023 was $34.16M, representing a decrease of -42.17% compared to 2022.

What is OmniAb’s quarterly revenue?

OmniAb's quarterly revenue for Q3 2025 was $2.24M, a -42.55% decrease from the previous quarter (Q2 2025), and a -46.33% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $3.9M, a -6.19% decrease from the previous quarter (Q1 2025), and a -48.82% decrease year-over-year (Q2 2024). OABI's quarterly revenue for Q1 2025 was $4.15M, a -61.55% decrease from the previous quarter (Q4 2024), and a 9.29% increase year-over-year (Q1 2024).

What is OmniAb’s revenue growth rate?

OmniAb's revenue growth rate for the last 3 years (2023-2025) was -45.36%, and for the last 5 years (2021-2025) was -46.28%.

What are OmniAb’s revenue streams?

OmniAb's revenue streams in c 25 are Service, and Royalty. Service generated $7.26M in revenue, accounting 89.22% of the company's total revenue, down -39.22% year-over-year. Royalty generated $878K in revenue, accounting 10.78% of the company's total revenue, up 52.43% year-over-year.

What is OmniAb’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of OmniAb was Service. This segment made a revenue of $7.26M, representing 89.22% of the company's total revenue.